Hemp THC Bans Are Already Lifting MSO Revenue

Photo by Pharma Hemp Complex via Unsplash.

Ohio cannabis sales are up 25% since the state pushed hemp-derived THC products off shelves outside licensed marijuana retailers at the end of March, according to MJBizDaily.

The number surfaced on Verano's quarterly earnings call. Verano is the first major multistate operator to report third-quarter results, so its commentary is the first real read on whether hemp bans actually move money into licensed dispensaries. Other MSOs, Green Thumb Industries among them, report the following week.

Treat the figure with care. It comes from one state and, as far as the reporting shows, one company's commentary. And a federal deadline later this year could reshape the whole picture.

What Verano Saw in Ohio

Ohio's restrictions on hemp THC products sold outside licensed marijuana retailers took effect at the end of March 2026. MJBizDaily reports that Ohio cannabis sales have risen 25% since the ban began. That is a large jump for a mature, regulated market.

On Verano's call, Archos said the company had seen continued growth for the entire Ohio market. The wording matters: he was describing the state's market as a whole, not just Verano's own stores. (The excerpt doesn't give his title; he is presumably CEO George Archos, but confirm that.)

Archos called the sales boost a notable positive trend that correlates with the start of the ban. He said it indicates hemp consumers are shifting toward licensed dispensaries.

Two cautions belong here. It is unclear whether the 25% figure comes from state sales data or from company commentary, and that distinction decides how much weight it can carry. And correlation is not proof of cause. Seasonality, new store openings and price changes can all move a state's totals, so the timing is suggestive rather than conclusive.

Verano's Ohio-specific revenue and its third-quarter totals weren't available to me, and they would help show how much of the lift reached the company itself.

Why Hemp Shoppers Are Walking Into Dispensaries

Think about who was buying hemp-derived THC. Gummies, drinks and vapes sat on shelves at gas stations and smoke shops, and were sold online, often at price points and in formats that competed head-on with licensed products. For many shoppers, the distinction between hemp and marijuana was never a priority.

Remove those shelves and the demand doesn't vanish. A customer who wanted a THC gummy last month still wants one. Licensed retail is the legal option left standing, and that makes the dispensary the natural place to land.

Licensed products also come with a pitch that converted shoppers can understand. State-mandated testing and labeling are baked into the marijuana system, which gives a budtender something concrete to say to a first-time visitor who bought unlabeled products at a corner store.

Scale is the reason operators care. MJBizDaily puts the hemp cannabinoid sector at an estimated $38 billion a year. Even a small share of that migrating into licensed channels would be meaningful to a dispensary chain.

Not every lost hemp sale becomes a dispensary sale, though. Some buyers will turn to the illicit market, and others will cross state lines to where products remain available. The 25% number tells us some money moved. It doesn't tell us how much escaped.

The Federal Clock Behind the State Bans

Photo by Hagar Lotte Geyer via Unsplash.

State bans don't exist in a vacuum. A federal change looms behind them, and details of it appear in cbdMD's 10-Q for the period ended June 30, 2026. These federal items are as reported in that filing, so check current status before relying on them.

Section 781 of the federal Act narrows the definition of hemp to a total THC standard that includes THCA. It also limits hemp-derived consumable products to 0.4 mg of total THC per container. The filing gives November 12, 2026 as the date the synthetic cannabinoid restrictions would take effect.

Congress has been moving, but not decisively:

• April 30, 2026: the House passed the Farm, Food, and National Security Act of 2026 (H.R. 7567), which did not modify Section 781's restrictions on finished hemp-derived cannabinoid products.
• July 22, 2026: Reps. Andy Barr and Angie Craig introduced the bipartisan, White House-supported Lawful Hemp Protection Act.
• August 2, 2026: a Senate stopgap appropriations proposal was released, running through December 11, 2026. It would temporarily exempt naturally occurring cannabinoids from the total-THC definition and the 0.4 mg limit, while synthetic restrictions would still start November 12.
• August 6, 2026: the Senate Agriculture Committee's competing markup failed 10-11 and also left Section 781 unchanged.

I couldn't confirm whether the stopgap was enacted. Anyone making business decisions should check the live status of each item.

Who Loses, and What MSOs Should Not Assume

Roughly 61-64% of cbdMD's revenue comes from products that already meet the Act's THC limits, with the share slightly higher in the most recent quarter (64%) than over the nine months (61%).

The losers in Ohio are easy to identify. MJBizDaily reports that hemp operators are shutting down amid law enforcement raids enforcing state restrictions. For a retailer whose shelf space depended on THC drinks and gummies, a state ban is an existential event.

Exposure varies widely, though. cbdMD said 64% of its revenue for the three months ended June 30, 2026 came from products that would comply with the Act's THC limits, and 61% for the nine months. It also warned that a meaningful amount of revenue could be affected if legislation does not change. So some hemp brands carry real risk, and others have a large compliant core and will survive.

MSOs should be careful about extrapolating. One state's bump does not guarantee a national pattern. Other states' hemp bans differ in scope and timing, and I haven't verified which have taken effect or when, so that homework remains.

The practical next step is to watch the coming reports from Green Thumb, Curaleaf, Trulieve and the other large operators. If their commentary describes similar shifts in states with hemp restrictions, Verano's Ohio story starts to look like a pattern. If it doesn't, Ohio may be a local quirk.

Ohio is an early data point, not a trend line. One quarter in one state, reported largely through a company's own commentary, is worth noting and not yet worth building a thesis on.

The bigger test is November 12 and whatever Congress does before it. A federal squeeze on hemp-derived THC would turn Ohio-style shifts into a national question for licensed operators, with a very different scale of consequences.

Readers should check their own state's hemp and marijuana rules. Legality and enforcement differ widely, and what holds in Ohio may not apply where you live or operate.

Browse our seed collection.